1 Market Overview

1.1 Product Overview and Scope of Cystic Fibrosis Treatment

1.2 Classification of Cystic Fibrosis Treatment by Type

1.2.1 Overview: Global Cystic Fibrosis Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Cystic Fibrosis Treatment Revenue Market Share by Type in 2021

1.2.3 Oral

1.2.4 Injection

1.3 Global Cystic Fibrosis Treatment Market by Application

1.3.1 Overview: Global Cystic Fibrosis Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Cystic Fibrosis Treatment Market Size & Forecast

1.5 Global Cystic Fibrosis Treatment Market Size and Forecast by Region

1.5.1 Global Cystic Fibrosis Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Cystic Fibrosis Treatment Market Size by Region, (2017-2022)

1.5.3 North America Cystic Fibrosis Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Cystic Fibrosis Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Cystic Fibrosis Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Cystic Fibrosis Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Cystic Fibrosis Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cystic Fibrosis Treatment Market Drivers

1.6.2 Cystic Fibrosis Treatment Market Restraints

1.6.3 Cystic Fibrosis Treatment Trends Analysis

2 Company Profiles

2.1 Actavis

2.1.1 Actavis Details

2.1.2 Actavis Major Business

2.1.3 Actavis Cystic Fibrosis Treatment Product and Solutions

2.1.4 Actavis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Actavis Recent Developments and Future Plans

2.2 F. Hoffmann-La Roche

2.2.1 F. Hoffmann-La Roche Details

2.2.2 F. Hoffmann-La Roche Major Business

2.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Product and Solutions

2.2.4 F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.3 Gilead Sciences

2.3.1 Gilead Sciences Details

2.3.2 Gilead Sciences Major Business

2.3.3 Gilead Sciences Cystic Fibrosis Treatment Product and Solutions

2.3.4 Gilead Sciences Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Gilead Sciences Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Cystic Fibrosis Treatment Product and Solutions

2.4.4 Novartis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis Recent Developments and Future Plans

2.5 Vertex Pharmaceuticals

2.5.1 Vertex Pharmaceuticals Details

2.5.2 Vertex Pharmaceuticals Major Business

2.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

2.5.4 Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Vertex Pharmaceuticals Recent Developments and Future Plans

2.6 Abbott

2.6.1 Abbott Details

2.6.2 Abbott Major Business

2.6.3 Abbott Cystic Fibrosis Treatment Product and Solutions

2.6.4 Abbott Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Abbott Recent Developments and Future Plans

2.7 Anthera Pharmaceuticals

2.7.1 Anthera Pharmaceuticals Details

2.7.2 Anthera Pharmaceuticals Major Business

2.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

2.7.4 Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Anthera Pharmaceuticals Recent Developments and Future Plans

2.8 Arcturus Therapeutics

2.8.1 Arcturus Therapeutics Details

2.8.2 Arcturus Therapeutics Major Business

2.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Product and Solutions

2.8.4 Arcturus Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Arcturus Therapeutics Recent Developments and Future Plans

2.9 Boehringer Ingelheim

2.9.1 Boehringer Ingelheim Details

2.9.2 Boehringer Ingelheim Major Business

2.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Product and Solutions

2.9.4 Boehringer Ingelheim Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Boehringer Ingelheim Recent Developments and Future Plans

2.10 Chiesi Farmaceutici

2.10.1 Chiesi Farmaceutici Details

2.10.2 Chiesi Farmaceutici Major Business

2.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Product and Solutions

2.10.4 Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Chiesi Farmaceutici Recent Developments and Future Plans

2.11 Corbus Pharmaceuticals

2.11.1 Corbus Pharmaceuticals Details

2.11.2 Corbus Pharmaceuticals Major Business

2.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

2.11.4 Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Corbus Pharmaceuticals Recent Developments and Future Plans

2.12 Genzyme

2.12.1 Genzyme Details

2.12.2 Genzyme Major Business

2.12.3 Genzyme Cystic Fibrosis Treatment Product and Solutions

2.12.4 Genzyme Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Genzyme Recent Developments and Future Plans

2.13 Insmed

2.13.1 Insmed Details

2.13.2 Insmed Major Business

2.13.3 Insmed Cystic Fibrosis Treatment Product and Solutions

2.13.4 Insmed Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Insmed Recent Developments and Future Plans

2.14 Johnson & Johnson

2.14.1 Johnson & Johnson Details

2.14.2 Johnson & Johnson Major Business

2.14.3 Johnson & Johnson Cystic Fibrosis Treatment Product and Solutions

2.14.4 Johnson & Johnson Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Johnson & Johnson Recent Developments and Future Plans

2.15 Merck Sharp & Dohme

2.15.1 Merck Sharp & Dohme Details

2.15.2 Merck Sharp & Dohme Major Business

2.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Product and Solutions

2.15.4 Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Merck Sharp & Dohme Recent Developments and Future Plans

2.16 Neovii Biotech

2.16.1 Neovii Biotech Details

2.16.2 Neovii Biotech Major Business

2.16.3 Neovii Biotech Cystic Fibrosis Treatment Product and Solutions

2.16.4 Neovii Biotech Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Neovii Biotech Recent Developments and Future Plans

2.17 Novo Nordisk

2.17.1 Novo Nordisk Details

2.17.2 Novo Nordisk Major Business

2.17.3 Novo Nordisk Cystic Fibrosis Treatment Product and Solutions

2.17.4 Novo Nordisk Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Novo Nordisk Recent Developments and Future Plans

2.18 PharmaSwiss

2.18.1 PharmaSwiss Details

2.18.2 PharmaSwiss Major Business

2.18.3 PharmaSwiss Cystic Fibrosis Treatment Product and Solutions

2.18.4 PharmaSwiss Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 PharmaSwiss Recent Developments and Future Plans

2.19 Pharmaxis

2.19.1 Pharmaxis Details

2.19.2 Pharmaxis Major Business

2.19.3 Pharmaxis Cystic Fibrosis Treatment Product and Solutions

2.19.4 Pharmaxis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Pharmaxis Recent Developments and Future Plans

2.20 Proteostasis Therapeutics

2.20.1 Proteostasis Therapeutics Details

2.20.2 Proteostasis Therapeutics Major Business

2.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Product and Solutions

2.20.4 Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Proteostasis Therapeutics Recent Developments and Future Plans

2.21 PTC Therapeutics

2.21.1 PTC Therapeutics Details

2.21.2 PTC Therapeutics Major Business

2.21.3 PTC Therapeutics Cystic Fibrosis Treatment Product and Solutions

2.21.4 PTC Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 PTC Therapeutics Recent Developments and Future Plans

2.22 United Medical

2.22.1 United Medical Details

2.22.2 United Medical Major Business

2.22.3 United Medical Cystic Fibrosis Treatment Product and Solutions

2.22.4 United Medical Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 United Medical Recent Developments and Future Plans

2.23 Venus Remedies

2.23.1 Venus Remedies Details

2.23.2 Venus Remedies Major Business

2.23.3 Venus Remedies Cystic Fibrosis Treatment Product and Solutions

2.23.4 Venus Remedies Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23.5 Venus Remedies Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cystic Fibrosis Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Cystic Fibrosis Treatment Players Market Share in 2021

3.2.2 Top 10 Cystic Fibrosis Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Cystic Fibrosis Treatment Players Head Office, Products and Services Provided

3.4 Cystic Fibrosis Treatment Mergers & Acquisitions

3.5 Cystic Fibrosis Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cystic Fibrosis Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Cystic Fibrosis Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Cystic Fibrosis Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Cystic Fibrosis Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Cystic Fibrosis Treatment Revenue by Type (2017-2028)

6.2 North America Cystic Fibrosis Treatment Revenue by Application (2017-2028)

6.3 North America Cystic Fibrosis Treatment Market Size by Country

6.3.1 North America Cystic Fibrosis Treatment Revenue by Country (2017-2028)

6.3.2 United States Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Cystic Fibrosis Treatment Revenue by Type (2017-2028)

7.2 Europe Cystic Fibrosis Treatment Revenue by Application (2017-2028)

7.3 Europe Cystic Fibrosis Treatment Market Size by Country

7.3.1 Europe Cystic Fibrosis Treatment Revenue by Country (2017-2028)

7.3.2 Germany Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

7.3.3 France Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cystic Fibrosis Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Cystic Fibrosis Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region

8.3.1 Asia-Pacific Cystic Fibrosis Treatment Revenue by Region (2017-2028)

8.3.2 China Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8.3.5 India Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Cystic Fibrosis Treatment Revenue by Type (2017-2028)

9.2 South America Cystic Fibrosis Treatment Revenue by Application (2017-2028)

9.3 South America Cystic Fibrosis Treatment Market Size by Country

9.3.1 South America Cystic Fibrosis Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cystic Fibrosis Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Cystic Fibrosis Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country

10.3.1 Middle East & Africa Cystic Fibrosis Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Cystic Fibrosis Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cystic Fibrosis Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Cystic Fibrosis Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Cystic Fibrosis Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Cystic Fibrosis Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Cystic Fibrosis Treatment Revenue Market Share by Region (2023-2028)

Table 6. Actavis Corporate Information, Head Office, and Major Competitors

Table 7. Actavis Major Business

Table 8. Actavis Cystic Fibrosis Treatment Product and Solutions

Table 9. Actavis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 11. F. Hoffmann-La Roche Major Business

Table 12. F. Hoffmann-La Roche Cystic Fibrosis Treatment Product and Solutions

Table 13. F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 15. Gilead Sciences Major Business

Table 16. Gilead Sciences Cystic Fibrosis Treatment Product and Solutions

Table 17. Gilead Sciences Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Cystic Fibrosis Treatment Product and Solutions

Table 21. Novartis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Vertex Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Vertex Pharmaceuticals Major Business

Table 24. Vertex Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

Table 25. Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Abbott Corporate Information, Head Office, and Major Competitors

Table 27. Abbott Major Business

Table 28. Abbott Cystic Fibrosis Treatment Product and Solutions

Table 29. Abbott Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Anthera Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Anthera Pharmaceuticals Major Business

Table 32. Anthera Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

Table 33. Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Arcturus Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Arcturus Therapeutics Major Business

Table 36. Arcturus Therapeutics Cystic Fibrosis Treatment Product and Solutions

Table 37. Arcturus Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 39. Boehringer Ingelheim Major Business

Table 40. Boehringer Ingelheim Cystic Fibrosis Treatment Product and Solutions

Table 41. Boehringer Ingelheim Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Chiesi Farmaceutici Corporate Information, Head Office, and Major Competitors

Table 43. Chiesi Farmaceutici Major Business

Table 44. Chiesi Farmaceutici Cystic Fibrosis Treatment Product and Solutions

Table 45. Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Corbus Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Corbus Pharmaceuticals Major Business

Table 48. Corbus Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions

Table 49. Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Genzyme Corporate Information, Head Office, and Major Competitors

Table 51. Genzyme Major Business

Table 52. Genzyme Cystic Fibrosis Treatment Product and Solutions

Table 53. Genzyme Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Insmed Corporate Information, Head Office, and Major Competitors

Table 55. Insmed Major Business

Table 56. Insmed Cystic Fibrosis Treatment Product and Solutions

Table 57. Insmed Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 59. Johnson & Johnson Major Business

Table 60. Johnson & Johnson Cystic Fibrosis Treatment Product and Solutions

Table 61. Johnson & Johnson Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Merck Sharp & Dohme Corporate Information, Head Office, and Major Competitors

Table 63. Merck Sharp & Dohme Major Business

Table 64. Merck Sharp & Dohme Cystic Fibrosis Treatment Product and Solutions

Table 65. Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Neovii Biotech Corporate Information, Head Office, and Major Competitors

Table 67. Neovii Biotech Major Business

Table 68. Neovii Biotech Cystic Fibrosis Treatment Product and Solutions

Table 69. Neovii Biotech Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 71. Novo Nordisk Major Business

Table 72. Novo Nordisk Cystic Fibrosis Treatment Product and Solutions

Table 73. Novo Nordisk Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. PharmaSwiss Corporate Information, Head Office, and Major Competitors

Table 75. PharmaSwiss Major Business

Table 76. PharmaSwiss Cystic Fibrosis Treatment Product and Solutions

Table 77. PharmaSwiss Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Pharmaxis Corporate Information, Head Office, and Major Competitors

Table 79. Pharmaxis Major Business

Table 80. Pharmaxis Cystic Fibrosis Treatment Product and Solutions

Table 81. Pharmaxis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Proteostasis Therapeutics Corporate Information, Head Office, and Major Competitors

Table 83. Proteostasis Therapeutics Major Business

Table 84. Proteostasis Therapeutics Cystic Fibrosis Treatment Product and Solutions

Table 85. Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. PTC Therapeutics Corporate Information, Head Office, and Major Competitors

Table 87. PTC Therapeutics Major Business

Table 88. PTC Therapeutics Cystic Fibrosis Treatment Product and Solutions

Table 89. PTC Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. United Medical Corporate Information, Head Office, and Major Competitors

Table 91. United Medical Major Business

Table 92. United Medical Cystic Fibrosis Treatment Product and Solutions

Table 93. United Medical Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Venus Remedies Corporate Information, Head Office, and Major Competitors

Table 95. Venus Remedies Major Business

Table 96. Venus Remedies Cystic Fibrosis Treatment Product and Solutions

Table 97. Venus Remedies Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 98. Global Cystic Fibrosis Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 99. Global Cystic Fibrosis Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 100. Breakdown of Cystic Fibrosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Cystic Fibrosis Treatment Players Head Office, Products and Services Provided

Table 102. Cystic Fibrosis Treatment Mergers & Acquisitions in the Past Five Years

Table 103. Cystic Fibrosis Treatment New Entrants and Expansion Plans

Table 104. Global Cystic Fibrosis Treatment Revenue (USD Million) by Type (2017-2022)

Table 105. Global Cystic Fibrosis Treatment Revenue Share by Type (2017-2022)

Table 106. Global Cystic Fibrosis Treatment Revenue Forecast by Type (2023-2028)

Table 107. Global Cystic Fibrosis Treatment Revenue by Application (2017-2022)

Table 108. Global Cystic Fibrosis Treatment Revenue Forecast by Application (2023-2028)

Table 109. North America Cystic Fibrosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 110. North America Cystic Fibrosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 111. North America Cystic Fibrosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 112. North America Cystic Fibrosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 113. North America Cystic Fibrosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 114. North America Cystic Fibrosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 115. Europe Cystic Fibrosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 116. Europe Cystic Fibrosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 117. Europe Cystic Fibrosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 118. Europe Cystic Fibrosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 119. Europe Cystic Fibrosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 120. Europe Cystic Fibrosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 121. Asia-Pacific Cystic Fibrosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 122. Asia-Pacific Cystic Fibrosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 123. Asia-Pacific Cystic Fibrosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 124. Asia-Pacific Cystic Fibrosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 125. Asia-Pacific Cystic Fibrosis Treatment Revenue by Region (2017-2022) & (USD Million)

Table 126. Asia-Pacific Cystic Fibrosis Treatment Revenue by Region (2023-2028) & (USD Million)

Table 127. South America Cystic Fibrosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 128. South America Cystic Fibrosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 129. South America Cystic Fibrosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 130. South America Cystic Fibrosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 131. South America Cystic Fibrosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 132. South America Cystic Fibrosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 133. Middle East & Africa Cystic Fibrosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 134. Middle East & Africa Cystic Fibrosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 135. Middle East & Africa Cystic Fibrosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 136. Middle East & Africa Cystic Fibrosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 137. Middle East & Africa Cystic Fibrosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 138. Middle East & Africa Cystic Fibrosis Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Cystic Fibrosis Treatment Picture

Figure 2. Global Cystic Fibrosis Treatment Revenue Market Share by Type in 2021

Figure 3. Oral

Figure 4. Injection

Figure 5. Cystic Fibrosis Treatment Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Clinics Picture

Figure 8. Other Picture

Figure 9. Global Cystic Fibrosis Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Cystic Fibrosis Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Cystic Fibrosis Treatment Revenue Market Share by Region (2017-2028)

Figure 12. Global Cystic Fibrosis Treatment Revenue Market Share by Region in 2021

Figure 13. North America Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Cystic Fibrosis Treatment Market Drivers

Figure 19. Cystic Fibrosis Treatment Market Restraints

Figure 20. Cystic Fibrosis Treatment Market Trends

Figure 21. Actavis Recent Developments and Future Plans

Figure 22. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 23. Gilead Sciences Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Vertex Pharmaceuticals Recent Developments and Future Plans

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Anthera Pharmaceuticals Recent Developments and Future Plans

Figure 28. Arcturus Therapeutics Recent Developments and Future Plans

Figure 29. Boehringer Ingelheim Recent Developments and Future Plans

Figure 30. Chiesi Farmaceutici Recent Developments and Future Plans

Figure 31. Corbus Pharmaceuticals Recent Developments and Future Plans

Figure 32. Genzyme Recent Developments and Future Plans

Figure 33. Insmed Recent Developments and Future Plans

Figure 34. Johnson & Johnson Recent Developments and Future Plans

Figure 35. Merck Sharp & Dohme Recent Developments and Future Plans

Figure 36. Neovii Biotech Recent Developments and Future Plans

Figure 37. Novo Nordisk Recent Developments and Future Plans

Figure 38. PharmaSwiss Recent Developments and Future Plans

Figure 39. Pharmaxis Recent Developments and Future Plans

Figure 40. Proteostasis Therapeutics Recent Developments and Future Plans

Figure 41. PTC Therapeutics Recent Developments and Future Plans

Figure 42. United Medical Recent Developments and Future Plans

Figure 43. Venus Remedies Recent Developments and Future Plans

Figure 44. Global Cystic Fibrosis Treatment Revenue Share by Players in 2021

Figure 45. Cystic Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 46. Global Top 3 Players Cystic Fibrosis Treatment Revenue Market Share in 2021

Figure 47. Global Top 10 Players Cystic Fibrosis Treatment Revenue Market Share in 2021

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 49. Global Cystic Fibrosis Treatment Revenue Share by Type in 2021

Figure 50. Global Cystic Fibrosis Treatment Market Share Forecast by Type (2023-2028)

Figure 51. Global Cystic Fibrosis Treatment Revenue Share by Application in 2021

Figure 52. Global Cystic Fibrosis Treatment Market Share Forecast by Application (2023-2028)

Figure 53. North America Cystic Fibrosis Treatment Sales Market Share by Type (2017-2028)

Figure 54. North America Cystic Fibrosis Treatment Sales Market Share by Application (2017-2028)

Figure 55. North America Cystic Fibrosis Treatment Revenue Market Share by Country (2017-2028)

Figure 56. United States Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Canada Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Mexico Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Europe Cystic Fibrosis Treatment Sales Market Share by Type (2017-2028)

Figure 60. Europe Cystic Fibrosis Treatment Sales Market Share by Application (2017-2028)

Figure 61. Europe Cystic Fibrosis Treatment Revenue Market Share by Country (2017-2028)

Figure 62. Germany Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. France Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. United Kingdom Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Russia Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Italy Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Asia-Pacific Cystic Fibrosis Treatment Sales Market Share by Type (2017-2028)

Figure 68. Asia-Pacific Cystic Fibrosis Treatment Sales Market Share by Application (2017-2028)

Figure 69. Asia-Pacific Cystic Fibrosis Treatment Revenue Market Share by Region (2017-2028)

Figure 70. China Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Japan Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South Korea Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. India Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Southeast Asia Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Australia Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South America Cystic Fibrosis Treatment Sales Market Share by Type (2017-2028)

Figure 77. South America Cystic Fibrosis Treatment Sales Market Share by Application (2017-2028)

Figure 78. South America Cystic Fibrosis Treatment Revenue Market Share by Country (2017-2028)

Figure 79. Brazil Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Argentina Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Middle East and Africa Cystic Fibrosis Treatment Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Cystic Fibrosis Treatment Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Cystic Fibrosis Treatment Revenue Market Share by Country (2017-2028)

Figure 84. Turkey Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Saudi Arabia Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. UAE Cystic Fibrosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source